Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Merck
Queensland Health
Boehringer Ingelheim
Fuji
Cipla
Cerilliant
Chinese Patent Office
Chubb

Generated: May 24, 2018

DrugPatentWatch Database Preview

MENTAX-TC Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Mentax-tc patents expire, and when can generic versions of Mentax-tc launch?

Mentax-tc is a drug marketed by Mylan and is included in one NDA.

The generic ingredient in MENTAX-TC is butenafine hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for MENTAX-TC
Drug patent expirations by year for MENTAX-TC
Synonyms for MENTAX-TC
(4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine
(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
[(4-tert-butylphenyl)methyl](methyl)(naphthalen-1-ylmethyl)amine
1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine; Butenafin
1-Naphthalenemethanamine,N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-methyl-
101828-21-1
4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine
4-tert-Butylbenzyl(methyl)(1-naphthalenemethyl)amine;4-tert-Butylbenzyl(methyl)(1-naphthalenemethyl)amine
828B211
91Y494NL0X
AB00053744_03
AB00053744-02
AB0013406
ABJKWBDEJIDSJZ-UHFFFAOYSA-N
AC-13296
AC1L1DS8
AKOS015894905
AN-34252
API0001791
AS-13357
BDBM50436713
BIDD:GT0236
Butenafin
Butenafina
Butenafina [INN-Spanish]
butenafine
Butenafine (INN)
Butenafine [INN:BAN]
Butenafine [INN]
Butenafinum
Butenafinum [INN-Latin]
Butop (TN)
C-19529
C08067
C23H27N
CAS-101828-21-1
CC-25279
CHEBI:3238
CHEMBL990
CTK8E8391
D07596
D0B4DC
DB01091
DivK1c_007016
DL-101
DR001382
DSSTox_CID_20657
DSSTox_GSID_40657
DSSTox_RID_79525
DTXSID7040657
FT-0631018
H989
HMS2089O04
I06-0093
J-000500
KBio1_001960
KBio2_002033
KBio2_004601
KBio2_007169
KBioSS_002033
KP 363
KP-363
KP-363|||Mentax|||1-(4-tert-Butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
Lotrimin Ultra
LS-171795
Mentax
Mentax (TN)
MolPort-002-885-811
N-(4-tert-Butylbenzyl)-N-methyl-1-naphthylmethylamin
N-(4-tert-Butylbenzyl)-n-methyl-1-naphthylmethylamine
N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine
N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride
N-methyl-N-(4'-t-butylbenzyl)-1-naphthylmethylamine
N-p-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine
NCGC00159511-02
NCGC00159511-03
NCGC00159511-04
OR193990
RT-011833
SC-17331
SCHEMBL65526
SpecPlus_000920
Spectrum_001553
Tox21 111729
Tox21_111729
Tox21_111729_1
UNII-91Y494NL0X
VA10450
X5950
ZINC1530975

US Patents and Regulatory Information for MENTAX-TC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan MENTAX-TC butenafine hydrochloride CREAM;TOPICAL 021408-001 Oct 17, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Farmers Insurance
Colorcon
Cantor Fitzgerald
UBS
Argus Health
Merck
Julphar
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.